Health Care Stocks That Beat the S&P 500 Most Consistently
Steady sector leaders, not one-month wonders
Updated August 30, 2026
Sector rotation makes raw-return lists whiplash — a sector’s whole cohort looks brilliant in its quarter and terrible after. Weekly consistency cuts through that: it asks which Health Care names finished ahead of the index week after week, through their sector’s good stretches and bad ones. For scale: the typical Health Care stock managed 25 winning weeks of 52.
| # | Stock | Weeks > SPY | 1Y excess | 1Y return | 1M |
|---|---|---|---|---|---|
| 1 | CRLCharles River Laboratories | 32 / 52 | +57.0% | +79.1% | +24.2% |
| Beat the S&P 500 in 32 of its last 52 weeks, on a +79.1% total return — +57.0% ahead of the index for the year. | |||||
| 2 | BIIBBiogen | 30 / 52 | +31.7% | +60.2% | +5.1% |
| Beat the S&P 500 in 30 of its last 52 weeks, on a +60.2% total return — +31.7% ahead of the index for the year. | |||||
| 3 | HUMHumana | 30 / 52 | +27.2% | +29.7% | +5.1% |
| Beat the S&P 500 in 30 of its last 52 weeks, on a +29.7% total return — +27.2% ahead of the index for the year. | |||||
| 4 | CNCCentene Corporation | 29 / 52 | +76.9% | +124.5% | +6.4% |
| Beat the S&P 500 in 29 of its last 52 weeks, on a +124.5% total return — +76.9% ahead of the index for the year. | |||||
| 5 | VTRSViatris | 29 / 52 | +29.2% | +56.8% | −8.0% |
| Beat the S&P 500 in 29 of its last 52 weeks, on a +56.8% total return — +29.2% ahead of the index for the year. | |||||
| 6 | WSTWest Pharmaceutical Services | 29 / 52 | +17.4% | +37.2% | −0.6% |
| Beat the S&P 500 in 29 of its last 52 weeks, on a +37.2% total return — +17.4% ahead of the index for the year. | |||||
| 7 | MCKMcKesson Corporation | 29 / 52 | +13.4% | +30.7% | +3.2% |
| Beat the S&P 500 in 29 of its last 52 weeks, on a +30.7% total return — +13.4% ahead of the index for the year. | |||||
| 8 | LLYLilly (Eli) | 28 / 52 | +38.7% | +59.8% | +1.5% |
| Beat the S&P 500 in 28 of its last 52 weeks, on a +59.8% total return — +38.7% ahead of the index for the year. | |||||
| 9 | WATWaters Corporation | 28 / 52 | +23.7% | +40.7% | +9.0% |
| Beat the S&P 500 in 28 of its last 52 weeks, on a +40.7% total return — +23.7% ahead of the index for the year. | |||||
| 10 | DGXQuest Diagnostics | 28 / 52 | +14.3% | +35.0% | +3.6% |
| Beat the S&P 500 in 28 of its last 52 weeks, on a +35.0% total return — +14.3% ahead of the index for the year. | |||||
| 11 | DXCMDexcom | 28 / 52 | −0.0% | +18.9% | +21.8% |
| Beat the S&P 500 in 28 of its last 52 weeks, on a +18.9% total return — −0.0% ahead of the index for the year. | |||||
| 12 | JNJJohnson & Johnson | 27 / 52 | +25.4% | +51.6% | +4.8% |
| Beat the S&P 500 in 27 of its last 52 weeks, on a +51.6% total return — +25.4% ahead of the index for the year. | |||||
| 13 | CVSCVS Health | 27 / 52 | +16.9% | +29.4% | −11.6% |
| Beat the S&P 500 in 27 of its last 52 weeks, on a +29.4% total return — +16.9% ahead of the index for the year. | |||||
| 14 | VRTXVertex Pharmaceuticals | 27 / 52 | +16.5% | +39.2% | +12.5% |
| Beat the S&P 500 in 27 of its last 52 weeks, on a +39.2% total return — +16.5% ahead of the index for the year. | |||||
| 15 | ELVElevance Health | 27 / 52 | +11.4% | +27.3% | +4.8% |
| Beat the S&P 500 in 27 of its last 52 weeks, on a +27.3% total return — +11.4% ahead of the index for the year. | |||||
| 16 | ABBVAbbVie | 27 / 52 | +5.6% | +22.8% | −0.8% |
| Beat the S&P 500 in 27 of its last 52 weeks, on a +22.8% total return — +5.6% ahead of the index for the year. | |||||
| 17 | CORCencora | 27 / 52 | −5.7% | +10.8% | +3.1% |
| Beat the S&P 500 in 27 of its last 52 weeks, on a +10.8% total return — −5.7% ahead of the index for the year. | |||||
| 18 | MRNAModerna | 26 / 52 | +215.4% | +449.8% | +138.2% |
| Beat the S&P 500 in 26 of its last 52 weeks, on a +449.8% total return — +215.4% ahead of the index for the year. | |||||
| 19 | RVTYRevvity | 26 / 52 | +23.2% | +45.4% | +13.4% |
| Beat the S&P 500 in 26 of its last 52 weeks, on a +45.4% total return — +23.2% ahead of the index for the year. | |||||
| 20 | REGNRegeneron Pharmaceuticals | 26 / 52 | +18.7% | +35.3% | +7.6% |
| Beat the S&P 500 in 26 of its last 52 weeks, on a +35.3% total return — +18.7% ahead of the index for the year. | |||||